RSC Publishing


Publishing

 

Cover image for Dalton Transactions, select for current issue

Dalton Transactions

The international journal for inorganic, organometallic and bioinorganic chemistry



Article b617769g is cited by the following journal articles

RSC journal articles

Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells
Journal of Analytical Atomic Spectrometry, 2009, 24, 51 Alexander E. Egger, Christina Rappel, Michael A. Jakupec, Christian G. Hartinger, Petra Heffeter, Bernhard K. Keppler
DOI: 10.1039/b810481f

From cisplatin to photoreactive Ru complexes: targeting DNA for biomedical applications
New Journal of Chemistry, 2009, 33, 235 Cécile Moucheron
DOI: 10.1039/b817016a

Lipid based nanovectors containing ruthenium complexes: a potential route in cancer therapy
Chemical Communications, 2009, 1404 Mauro Vaccaro, Raffaella Del Litto, Gaetano Mangiapia, Anna M. Carnerup, Gerardino DErrico, Francesco Ruffo, Luigi Paduano
DOI: 10.1039/b820368g

Photo-induced double-strand DNA and site-specific protein cleavage activity of L-histidine (-oxo)diiron(III) complexes of heterocyclic bases
Dalton Transactions, 2009, 4671 Mithun Roy, Tuhin Bhowmick, Ramkumar Santhanagopal, Suryanarayana Ramakumar, Akhil R. Chakravarty
DOI: 10.1039/b901337g

Recent developments in ruthenium anticancer drugs
Metallomics, 2009, 1, 458 Aviva Levina, Anannya Mitra, Peter A. Lay
DOI: 10.1039/b904071d

A categorization of metal anticancer compounds based on their mode of action
Dalton Transactions, 2009, 7588 Teresa Gianferrara, Ioannis Bratsos, Enzo Alessio
DOI: 10.1039/b905798f

An ethylene-glycol decorated ruthenium(II) complex for two-photon photodynamic therapy
Chemical Communications, 2009, 4590 Sanda C. Boca, Mickaël Four, Adeline Bonne, Boudewijn van der Sanden, Simion Astilean, Patrice L. Baldeck, Gilles Lemercier
DOI: 10.1039/b907143a

Inorganic pharmaceuticals
Annual Reports Section "A" (Inorganic Chemistry), 2008, 104, 477 LaMaryet Moody, Alvin A. Holder
DOI: 10.1039/b716590k

Metal based drugs: from serendipity to design
Dalton Transactions, 2007, 4903 Simon Paul Fricker
DOI: 10.1039/b705551j

Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior
Dalton Transactions, 2007, 4048 Ioannis Bratsos, Giovanni Birarda, Stephanie Jedner, Ennio Zangrando, Enzo Alessio
DOI: 10.1039/b707011j

Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives
Dalton Transactions, 2007, 3474 P. Manohari Abeysinghe, Margaret M. Harding
DOI: 10.1039/b707440a

Non-RSC journal articles

Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c
JBIC Journal of Biological Inorganic Chemistry, 2007, 12(8), 1107 Angela Casini, Guido Mastrobuoni, Mattia Terenghi, Chiara Gabbiani, Enrico Monzani, Gloriano Moneti, Luigi Casella, Luigi Messori
DOI: 10.1007/s00775-007-0280-4

Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand
Investigational New Drugs, 2009, 27(6), 503 Raj K. Koiri, Surendra K. Trigun, Lallan Mishra, Kiran Pandey, Deobrat Dixit, Santosh K. Dubey
DOI: 10.1007/s10637-008-9202-8

Osmium Carbonyl Clusters: A New Class of Apoptosis Inducing Agents
ChemMedChem, 2008, 3(8), 1269 KienVoon Kong, WengKee Leong, SweePhyaw Ng, ThanhHung Nguyen, LinaH.K. Lim
DOI: 10.1002/cmdc.200800069

New pharmacological strategies against metastatic spread
Fundamental & clinical Pharmacology, 2008, 22(5), 465 G.Y. Perret, M. Crepin
DOI: 10.1111/j.1472-8206.2008.00614.x

Photochemotherapy: Targeted Activation of Metal Anticancer Complexes
Australian Journal of Chemistry, 2008, 61(9), 669 Nicola J. Farrer, Peter J. Sadler
DOI: 10.1071/CH08088